X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with JYOTHY LABS - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs JYOTHY LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES JYOTHY LABS AMAR REMEDIES/
JYOTHY LABS
 
P/E (TTM) x -0.5 32.8 - View Chart
P/BV x 0.1 8.1 0.7% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 AMAR REMEDIES   JYOTHY LABS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
JYOTHY LABS
Mar-16
AMAR REMEDIES/
JYOTHY LABS
5-Yr Chart
Click to enlarge
High Rs164342 48.0%   
Low Rs86237 36.3%   
Sales per share (Unadj.) Rs261.690.9 287.8%  
Earnings per share (Unadj.) Rs17.48.7 199.4%  
Cash flow per share (Unadj.) Rs22.310.5 213.2%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %01.7 0.0%  
Book value per share (Unadj.) Rs100.746.7 215.6%  
Shares outstanding (eoy) m26.16181.12 14.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.53.2 15.0%   
Avg P/E ratio x7.233.2 21.6%  
P/CF ratio (eoy) x5.627.7 20.3%  
Price / Book Value ratio x1.26.2 20.0%  
Dividend payout %057.3 0.0%   
Avg Mkt Cap Rs m3,27052,434 6.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1631,661 9.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,84416,466 41.6%  
Other income Rs m21103 20.5%   
Total revenues Rs m6,86516,568 41.4%   
Gross profit Rs m1,1312,244 50.4%  
Depreciation Rs m128314 40.8%   
Interest Rs m39860 660.0%   
Profit before tax Rs m6261,973 31.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121393 30.8%   
Profit after tax Rs m4551,580 28.8%  
Gross profit margin %16.513.6 121.2%  
Effective tax rate %19.319.9 97.0%   
Net profit margin %6.69.6 69.3%  
BALANCE SHEET DATA
Current assets Rs m4,9044,536 108.1%   
Current liabilities Rs m3,5818,641 41.4%   
Net working cap to sales %19.3-24.9 -77.5%  
Current ratio x1.40.5 260.9%  
Inventory Days Days12440 306.9%  
Debtors Days Days10021 480.1%  
Net fixed assets Rs m1,68910,757 15.7%   
Share capital Rs m262181 144.7%   
"Free" reserves Rs m2,3587,722 30.5%   
Net worth Rs m2,6358,461 31.1%   
Long term debt Rs m50773 697.4%   
Total assets Rs m6,86217,673 38.8%  
Interest coverage x2.633.7 7.6%   
Debt to equity ratio x0.20 2,239.4%  
Sales to assets ratio x1.00.9 107.0%   
Return on assets %12.49.3 134.0%  
Return on equity %17.318.7 92.5%  
Return on capital %31.023.8 130.1%  
Exports to sales %4.00.7 534.4%   
Imports to sales %01.5 0.0%   
Exports (fob) Rs m273123 222.1%   
Imports (cif) Rs mNA242 0.0%   
Fx inflow Rs m273123 222.1%   
Fx outflow Rs m2269 0.7%   
Net fx Rs m271-146 -185.2%   
CASH FLOW
From Operations Rs m-3131,915 -16.3%  
From Investments Rs m-4893 -14,367.6%  
From Financial Activity Rs m769-3,025 -25.4%  
Net Cashflow Rs m-33-1,107 2.9%  

Share Holding

Indian Promoters % 25.5 66.8 38.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 8.4 109.0%  
FIIs % 0.0 14.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 10.3 634.0%  
Shareholders   13,061 84,983 15.4%  
Pledged promoter(s) holding % 99.7 36.7 271.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   GILLETTE INDIA  RELAXO FOOTWEARS  COLGATE  ARCHIES LTD  K.S.OILS LTD  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES - GODREJ INDUSTRIES COMPARISON

COMPARE AMAR REMEDIES WITH

MARKET STATS